Ignite Creation Date:
2024-05-06 @ 7:26 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06016543
Status:
COMPLETED
Last Update Posted:
2023-10-05
First Post:
2023-08-23
Brief Title:
Role of OMT in the Management of the Persistent Post-COVID-19 Symptoms
Sponsor:
AT Still University of Health Sciences
Organization:
AT Still University of Health Sciences
Study Overview
Official Title:
Role of OMT in the Management of the Persistent Post-COVID-19 Symptoms - A Pilot Prospective Cohort Study
Status:
COMPLETED
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ROMPS
Brief Summary:
The goal of this observational study is to determine the feasibility of conducting a large-scale study on the effect of using osteopathic manipulative treatment OMT to treat patients with post-COVID-19 symptoms The main questions it aims to answer are
1 Is it feasible to conduct a large-scale study of the effect of OMT on patients with post-COVID-19 symptoms based on how many patients agree to participate and how many complete the study
2 How much change in patients post-COVID-19 symptom severity quality of life and ability to return to work can we expect to see following OMT
Participants will receive OMT as directed by their physician and complete questionnaires after every other OMT session
1 Participants will complete questionnaires about their post-COVID-19 symptoms quality of life ability to return to work and adverse events they experienced 3 days after every other OMT session
2 Participants will be sent links to the questionnaires for 4 months or when their symptoms resolve whichever comes first
3 Additionally participants will complete a follow-up questionnaire 2 months after they stop receiving OMT for their post-COVID-19 symptoms or 6 months after enrollment in the study whichever comes first
1 Is it feasible to conduct a large-scale study of the effect of OMT on patients with post-COVID-19 symptoms based on how many patients agree to participate and how many complete the study
2 How much change in patients post-COVID-19 symptom severity quality of life and ability to return to work can we expect to see following OMT
Participants will receive OMT as directed by their physician and complete questionnaires after every other OMT session
1 Participants will complete questionnaires about their post-COVID-19 symptoms quality of life ability to return to work and adverse events they experienced 3 days after every other OMT session
2 Participants will be sent links to the questionnaires for 4 months or when their symptoms resolve whichever comes first
3 Additionally participants will complete a follow-up questionnaire 2 months after they stop receiving OMT for their post-COVID-19 symptoms or 6 months after enrollment in the study whichever comes first
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None